Revise Notes Psych Flashcards

1
Q

Korsakoff dementia

A

Korsakoff Dementia

Pathophysiology

Thiamine deficiency results in haemorrhage within the mamillary bodies of the thalamus and hypothalamus

Clinical Features

Anterograde amnesia - inability to form new memories
Retrograde amnesia with confabulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alcohol Related Disorders
Alcohol withdrawal

Pathophysiology

Alcohol results in the following:

Increased GABA mediated inhibition of the CNS (considered a depressant)
Inhibition of NMDA-type glutamate receptors

Therefore alcohol withdrawal results in

Reduced GABA levels leading to CNS overstimulation (disinhibition)
Increased NMDA-glutamate receptor activation

A

Clinical features

Symptoms often begin 6-12 hours following last drink and peak at approximately 36 hours

Tremor
Tachycardia
Confusion and agitation
Sweating
Delirium tremens can occur at 48-72 hrs and is characterised by
Coarse tremor
Confusion and delusions
Hallucinations

Management of alcohol withdrawal

CIWA scoring with a benzodiazepine, either

Diazepam
Chlordiazepoxide
Some trusts are now using alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Panic disorder

Panic disorder is a type of anxiety disorder characterised by sudden attacks of panic. These can occur at any time and for no clear reason.

Symptoms/signs include:

Palpitations and tachycardia
N&V
Chest pain
Hyperventilation/ SOB
Paraesthesia

A

Management - NICE guidance:

NICE advocates a stepwise approach

Step 1: Recognition and diagnosis of panic disorder

Step 2: Management within primary care – either:

Mild to moderate panic disorder:
Low intensity interventions - individual facilitated/non-facilitated self-help
Moderate to severe panic disorder:
CBT or

An antidepressant - SSRI (sertraline)

Nb. In panic disorder, after improvement, continue the antidepressant for a minimum of 6 months before tapering, to reduce the risk of relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Generalised anxiety disorder

Diagnosis of GAD

The DSM-5 criteria for a diagnosis of GAD includes the following symptoms for at least 6 months:

Excessive worry about everyday issues in a manner in which anxiety is disproportionate to risk
At least 3 of the following:
Nervousness/restlessness
Fatigue and tiredness all the time
Poor concentration
Irritability
Muscle tension e.g. in neck and shoulders – this can manifest as tension headaches
Disturbed sleep or insomnia

A validated questionnaire can be used to help identify the presence of these features, including:

A

The GAD-2 questionnaire
The GAD-7 questionnaire
7 questions scoring 0-3
5 = mild GAD
10 = moderate GAD
15 = severe GAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of Generalised Anxiety Disorder

NICE recommend the following stepwise process in the management of GAD

Step 1: Education and active monitoring

Step 2: Low-intensity psychological intervention

Individual, non-facilitated self help
Individual guided self help

Psychoeducational groups - group therapy based on CBT principles

Step 3: For patients with GAD with marked functional impairment OR GAD which has not responded to steps 1 and 2 - offer high-intensity psychological intervention OR pharmacological intervention

A

Psychological interventions include
Individual high intensity CBT

Applied relaxation - A therapy which focuses on relaxing mind and muscles in situations that would normally trigger anxiety

Pharmacological management
1st Line: SSRI – Sertraline
2nd line: Alternative SSRI (escitalopram/paroxetine) or SNRI (duloxetine/venlafaxine)
If these are contraindicated consider pregabalin

Step 4: Specialist referral

Note: Current guidance states that if the patient is improving with an antidepressant, it should be continued for at least 12 months to reduce the risk of relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Agoraphobia

An anxiety disorder which is characterised by an irrational fear of open spaces and crowds.

Patients have a phobia of leaving home, for fear of being in situations where there is no immediate safe place to escape to.

A

Agoraphobia

An anxiety disorder which is characterised by an irrational fear of open spaces and crowds.
Patients have a phobia of leaving home, for fear of being in situations where there is no immediate safe place to escape to.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Alcohol Related Disorders

Alcohol withdrawal

Pathophysiology

Alcohol results in the following:

Increased GABA mediated inhibition of the CNS (considered a depressant)
Inhibition of NMDA-type glutamate receptors
Therefore alcohol withdrawal results in

Reduced GABA levels leading to CNS overstimulation (disinhibition)
Increased NMDA-glutamate receptor activation

A

Clinical features

Symptoms often begin 6-12 hours following last drink and peak at approximately 36 hours
Tremor
Tachycardia
Confusion and agitation
Sweating

Delirium tremens can occur at 48-72 hrs and is characterised by
Coarse tremor
Confusion and delusions
Hallucinations

Management of alcohol withdrawal

CIWA scoring with a benzodiazepine, either

Diazepam
Chlordiazepoxide
Some trusts are now using alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Korsakoff Dementia

Pathophysiology

Thiamine deficiency results in haemorrhage within the mamillary bodies of the thalamus and hypothalamus

A

Clinical Features

Anterograde amnesia - inability to form new memories
Retrograde amnesia with confabulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

nxiety & Panic Disorder
Generalised anxiety disorder

Diagnosis of GAD

The DSM-5 criteria for a diagnosis of GAD includes the following symptoms for at least 6 months:

Excessive worry about everyday issues in a manner in which anxiety is disproportionate to risk

At least 3 of the following:
Nervousness/restlessness
Fatigue and tiredness all the time
Poor concentration

Irritability
Muscle tension e.g. in neck and shoulders – this can manifest as tension headaches

Disturbed sleep or insomnia
A validated questionnaire can be used to help identify the presence of these features, including:

The GAD-2 questionnaire
The GAD-7 questionnaire
7 questions scoring 0-3
5 = mild GAD
10 = moderate GAD
15 = severe GAD

A

Management of Generalised Anxiety Disorder

NICE recommend the following stepwise process in the management of GAD

Step 1: Education and active monitoring

Step 2: Low-intensity psychological intervention

Individual, non-facilitated self help
Individual guided self help
Psychoeducational groups - group therapy based on CBT principles

Step 3: For patients with GAD with marked functional impairment
OR GAD which has not responded to steps 1 and 2

  • offer high-intensity psychological intervention OR pharmacological intervention

Psychological interventions include
Individual high intensity CBT

Applied relaxation - A therapy which focuses on relaxing mind and muscles in situations that would normally trigger anxiety

Pharmacological management

1st Line: SSRI – Sertraline
2nd line: Alternative SSRI (escitalopram/paroxetine) or SNRI (duloxetine/venlafaxine)

If these are contraindicated consider pregabalin

Step 4: Specialist referral

Note: Current guidance states that if the patient is improving with an antidepressant, it should be continued for at least 12 months to reduce the risk of relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Panic disorder

Panic disorder is a type of anxiety disorder characterised by sudden attacks of panic. These can occur at any time and for no clear reason. Symptoms/signs include:

Palpitations and tachycardia
N&V
Chest pain
Hyperventilation/ SOB
Paraesthesia

A

Management - NICE guidance:

NICE advocates a stepwise approach

Step 1: Recognition and diagnosis of panic disorder

Step 2: Management within primary care – either:

Mild to moderate panic disorder:
Low intensity interventions - individual facilitated/non-facilitated self-help
Moderate to severe panic disorder:

CBT or
An antidepressant - SSRI (sertraline)
Nb. In panic disorder, after improvement,

continue the antidepressant for a minimum of 6 months before tapering, to reduce the risk of relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Agoraphobia

A

Agoraphobia

An anxiety disorder which is characterised by an irrational fear of open spaces and crowds. Patients have a phobia of leaving home, for fear of being in situations where there is no immediate safe place to escape to.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Suicide: Risk stratification

There is increased risk of attempted and completed suicide with:

A

Male sex
History of deliberate self harm (DSH)
History of alcohol/drug misuse

Background of mental health illness
History of chronic disease
Increasing age

Unemployment, lack of social network/isolation
Living alone, loneliness
Single/widowed or divorced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Electroconvulsive therapy (ECT)

A

Considered in cases of severe depression which is REFRACTORY to medical management

Absolute contraindication: Raised intracranial pressure

Adverse effects
Short term: Headache, short term memory loss, Arrhythmias
Long term: Impaired memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Seasonal Affective Disorder

A

Depressive symptoms occurring within the winter months

Management is the same as ‘typical’ depression (i.e. CBT and SSRIs if required etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Depression in elderly patients

Clinical features

Elderly patients are less likely to complain of depressed mood and may have atypical symptoms such as agitation or insomnia.

They may also be worried about memory loss and concerned about dementia -

the memory loss they experience is global (whereas dementia affects more recent memories)

Biological symptoms – weight loss, sleep disturbance

A

Management

1st Line: SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Depression

A

Depression
Depression is the most common mental health disorder in the UK and is characterised by low mood, fatigue and feelings of worthlessness.

Diagnosis of depression

Depression is diagnosed using the DSM-5 criteria

A diagnosis of depression can be made

if 5 or more of the following core symptoms are present for 2 weeks or more:
Depressed mood most of the time

Anhedonia - diminished enjoyment or pleasure in most activities
Weight change - Unintentional weight loss or weight gain

Slow thought or movement
Fatigue
Feelings of worthlessness
Difficulty concentrating or making decisions

Thoughts of death or suicidal ideation
Other symptoms include:
Sleep disturbance – decreased or increased
Abnormal appetite
Irritability

Classification of severity:
<5 symptoms = subthreshold depression

5-6 symptoms with minor functional impairment = mild depression

Moderate depression = somewhere in between mild/severe

Most/all of the above symptoms = severe depression, severe functional impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Assessment of depression

A

PHQ9 – assessment of symptoms over the last 2 weeks – 9 questions scoring 1-3 each

NICE classifies depression according to severity, using the PHQ-9 scale:

Less severe depression
A score of less than 16 on the PHQ-9 scale
Encompasses subthreshold and mild depression

More severe depression
A score of 16 or more on the PHQ-9 scale
Encompasses moderate and severe depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Management of depression

Less severe depression and does not want treatment/symptoms improving

A

Offer active monitoring and review in 2-4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Less severe depression and wants treatment

A

1st line: Offer guided self-help (e.g. CBT)

Do not routinely offer an
antidepressant. If the patient wants drug treatment, commence SSRI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

More severe depression

A

Offer any of the following as 1st line treatment options, depending on patient’s wishes:

Individual CBT
Antidepressant medication
Individual behavioural activation
Group exercise

If the patients wants to start treatment with an antidepressant - offer SSRI or SNRI 1st line
Review in 2-4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Choosing an antidepressant

A

First-line: SSRIs – Sertraline or citalopram preferred for most due to safety and tolerability.

Caution: Citalopram may prolong QTc, requiring ECG monitoring
SSRIs such as sertraline are also preferred in the context of physical health conditions, due to lower drug interaction risk.

Sertraline has been shown to be safe in patients with IHD such as unstable angina/recent MI

Fluoxetine is the preferred antidepressant for depression in children and young people.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
26
Depression in elderly patients Clinical features Elderly patients are less likely to complain of depressed mood and may have atypical symptoms such as agitation or insomnia. They may also be worried about memory loss and concerned about dementia - the memory loss they experience is global (whereas dementia affects more recent memories) Biological symptoms – weight loss, sleep disturbance
Management 1st Line: SSRI
27
Electroconvulsive therapy (ECT)
Considered in cases of severe depression which is REFRACTORY to medical management Absolute contraindication: Raised intracranial pressure Adverse effects Short term: Headache, short term memory loss, Arrhythmias Long term: Impaired memory
28
Seasonal Affective Disorder Depressive symptoms occurring within the winter months Management is the same as ‘typical’ depression (i.e. CBT and SSRIs if required etc.)
Seasonal Affective Disorder Depressive symptoms occurring within the winter months Management is the same as ‘typical’ depression (i.e. CBT and SSRIs if required etc.)
29
Suicide: Risk stratification There is increased risk of attempted and completed suicide with
: Male sex History of deliberate self harm (DSH) History of alcohol/drug misuse Background of mental health illness History of chronic disease Increasing age Unemployment, lack of social network/isolation Living alone, loneliness Single/widowed or divorced
30
Body dysmorphic disorder Clinical features
A preoccupation with an imagined defect in appearance resulting in distress (and does not fit diagnostic criteria of anorexia nervosa or bulimia nervosa).
31
Bulimia Nervosa Diagnosis Bulimia nervosa is diagnosed according to the DSM-5. Key features include Binge eating Followed by purging – excess exercise, laxative use, self-induced vomiting
Management: 1st Line: Bulimia-nervosa focussed guided self help 2nd line: (if BN-self help is ineffective or unacceptable) - Eating disorder focussed CBT (CBT-ED) Children & young people: Bulimia nervosa focussed family therapy (FT-BN) Pharmacological: Fluoxetine can be used in combination with therapy, but not alone.
32
Anorexia Nervosa Clinical features Low BMI or rapid weight loss Unexplained electrolyte imbalance or hypoglycaemia Oligo- amenorrhoea Observations: bradycardia, hypotension On examination: Parotid / salivary gland enlargement
Management Psychological treatments - include: eating disorder focussed CBT (CBT-ED), Maudsley Anoxrexia Nervosa Treatment Adults (MANTRA).
33
Mania
Mania & Bipolar Affective Disorder Mania Clinical features Abnormally elevated mood, agitation or irritability Hyperactivity, restlessness Speech - pressured, flight of ideas Disinhibition and increased libido Impulsive behaviours - gambling, spending sprees etc. There may be a history of psychotic symptoms - grandiose delusions, or auditory hallucinations Symptoms persist for at least 7 days for a formal diagnosis, and result in significant functional impairment
34
35
36
Hypo mania
Similar features to mania - but to a less severe extent, with less of a functional impairment (e.g. socially or at work). Psychotic features are NOT present Symptoms include a mild elevation of mood, irritability, hyperactivity, over-familiarity and talkativeness.
37
Mixed episode
Mixed episode Suggested by rapidly alternating symptoms of depression and the above features of mania or hypomania.
38
Bipolar affective disorder (BAD)
Bipolar affective disorder is a chronic mental health condition which is characterised by episodes of depression and hypomania or mania. The DSM-5 diagnostic criteria defines BAD as follows: Type 1 BAD: At least one episode of mania with or without a history of depressive episodes Type 2 BAD: One or more depressive episodes and at least one hypomanic episode (without mania)
39
Management of Mania / BAD
Treatment of acute mania or mixed episodes Step 1: Oral antipsychotic (haloperidol, quetiapine, risperidone or olanzapine) Step 2: If not effective or not tolerated, try an alternative antipsychotic from above Step 3: If not effective, add lithium (or sodium valproate as an alternative) Other: Stop or taper dose the dose of antidepressant medications
40
Management of Mania / BAD Depression RX
Treatment of depression Options include: Quetiapine Lamotrigine Olanzapine Olanzapine and fluoxetine
41
Long-Term Management of BAD
Four weeks following acute episode, either: Continue the antipsychotic/ current treatment for mania Or commence long term lithium to prevent relapse (and add valproate if req.) In addition, offer psychotherapy to all patients with BAD, or a high-intensity therapy for depression (e.g. CBT).
42
Antipsychotic Medications Antipsychotics can be categorised as typical and atypical. Typical antipsychotics were developed first, and are associated with a greater risk of extrapyramidal side effects. Typical (first generation) Antipsychotics Examples Haloperidol, Chlorpromazine Mechanism of action Dopamine (D2) Receptor Antagonists Important side effects
Hyperprolactinaemia - oligo-/amenorrhoea, loss of libido and erectile dysfunction, galactorrhoea Remember - dopamine inhibits prolactin release Extrapyramidal side effects - parkinsonism, dystonias, akathisia, tardive dyskinesia Antimuscarinic effects - dry mouth, blurred vision, urinary retention, constipation Impaired glucose tolerance Reduced seizure threshold - caution in patients with epilepsy
43
44
Extrapyramidal side effects
Drug induced parkinsonism Classically of rapid onset and features are symmetrical. Unlike IPD - symptoms are of gradual onset, and typically asymmetrical Akathisia A feeling of severe restlessness Tardive Dyskinesia Involuntary, slow writhing movements Classical movements include chewing, grimacing, tongue protrusion, lip smacking. Dystonias Sustained muscle contractions - oculogyric crisis / torticolis Torticolis - also referred to as 'wry neck' - severe neck muscle spasm/contraction resulting in involuntary head tilting Oculogyric Crisis - involuntary, extreme upward deviation of gaze +/- the presence of torticolis, tongue protrusion, jaw spasm
45
Management of acute dystonias
: Procyclidine (anticholinergic) or Benzatropine
46
Other complications of typical antipsychotics
Typical APs should be prescribed with caution in elderly patients, increasing the risk of stroke and DVT/PE. Neuroleptic Malignant Syndrome - see below Polymorphic VT/ Torsades de pointes - due to prolongation of the QTc (esp. with haloperidol)
47
48
Atypical (second generation) Antipsychotics Atypical antipsychotics are first line in schizophrenia
Mechanism of action Act on a wider variety of receptors (D2, D3, D4, 5-HT) Examples Olanzapine Risperidone Aripiprazole Quetiapine Clozapine Amisulpride Advantages Lower risk of extrapyramidal side effects (EPSEs) vs typical APs
49
Clozapine Clozapine is indicated in the management of schizophrenia, if symptoms are not adequately controlled despite the use of 2 or more antipsychotics for 6-8 weeks. This is due to its association with significant adverse effects, which include
: Agranulocytosis - FBC monitoring is essential Seizures Myocarditis - a baseline ECG is required before commencing treatment Constipation Clozapine induced Hypersalivation - a significant side effect, affecting approximately 1/3rd of patients. Hyoscine butylbromide can be prescribed to relieve hypersalivation
50
Atypical antipsychotics
Side effects Metabolic syndrome - weight gain, insulin resistance/diabetes, dyslipidemia - therefore associated with accelerated cardiovascular disease. Stroke and VTE (esp in elderly patients) EPSEs + hyperprolactinemia - less common
50
Neuroleptic Malignant Syndrome (NMS) A known complication associated with the use of antipsychotics. NMS can also be triggered by missed doses of levodopa/parkinson’s meds. Clinical features Pyrexia Muscle rigidity Agitation and delirium Autonomic lability - Hypertension and tachycardia
Examination findings Reduced or absent reflexes Normal pupils Differential diagnosis - serotonin syndrome - characterised by dilated pupils, myoclonus and brisk reflexes. Complications Rhabdomyolysis and resultant AKI Management Stop antipsychotics IV fluids Dantrolene Bromocriptine/ dopamine agonists may be beneficial
51
Antidepressants Selective Serotonin Reuptake Inhibitors (SSRIs) Mechanism of action Increase the extracellular levels of the neurotransmitter serotonin, by inhibiting its reuptake into the presynaptic cell. Examples Sertraline Fluoxetine Citalopram
Contraindications (NICE) Current mania Poorly controlled epilepsy Avoid citalopram/escitalopram if QT prolongation or in combination with other drugs which increase the QTc - risk of TDP Avoid sertraline in severe hepatic impairment SSRIs in cardiovascular disease Sertraline is safest Side effects of SSRIs Gastrointestinal side effects are the most common Consider PPI co-prescription (e.g. if on NSAIDs
52
Ssri interaction
Interactions/contraindications Use with caution with aspirin or NSAIDs – increased risk of PUD/GI bleed Avoid with warfarin or heparin due to bleeding risk – give mirtazapine instead Avoid co-prescribing triptans or MAOIs – risk of serotonin syndrome Follow up Patients should be followed up shortly after commencing SSRIs due to the risk of increased anxiety and suicidal ideation If < 30 years of age, follow patients up in 1 week If > 30 years – follow up in 2 weeks Stopping SSRIs If patients show a good response, they should continue SSRIs for at least another 6 months before discontinuation, or there is a high risk of symptom relapse. Stopping SSRIs suddenly can result in high risk of discontinuation syndrome Clinical features: restlessness, anxiety and agitation, GI symptoms (diarrhoea etc.) Gradually reduce dose over 4 weeks before stopping to reduce this risk Paroxetine - highest risk of discontinuation syndrome
53
Serotonin Syndrome Causes The following drugs are associated with serotonin syndrome, particularly if co-prescribed/ingested: SSRIs MAOIs Triptans Ecstasy/methamphetamines St Johns Wort.
Clinical Features Neuromuscular excitation: Increased reflexes, myoclonus, rigidity Autonomic lability – tachycardia, hypertension, pyrexia Confusion, agitation, aggression Note: Myoclonus is a useful differentiating feature from neuroleptic malignant syndrome Management IV fluids Benzodiazepines – the mainstay of management In severe serotonin syndrome – cyproheptadine or chlorpromazine can be used (serotonin antagonists)
54
SNRIs Mechanism of action Serotonin + noradrenaline reuptake inhibitors – increased levels of neurotransmitters at the synaptic cleft
Examples Venlafaxine Duloxetine
55
Monoamine oxidase inhibitors (MAOIs) Mechanism of action Reduce metabolism of serotonin and noradrenaline in the presynaptic clefts)
Examples Phenelzine Side effects MAOIs are associated with hypertension particularly if used whilst tyramine containing foods are eaten (cheese, herring, broad beans)
56
Tricyclic Antidepressants An old class of antidepressants which have a number of additional uses. For example, amitriptyline is used in the management of neuropathic pain & migraine prophylaxis.
Adverse effects Antimuscarinic effects – dry mouth, constipation, urinary retention, blurred vision Drowsiness Prolongation of the QTc (risk of TDP)
57
TCAs in overdose TCAs are considered the most dangerous antidepressants in overdose (esp. Amitriptyline and dosulepin)
Clinical features Drowsiness Dry mouth, blurred vision Pupils - dilated Arrhythmias Seizures Metabolic acidosis Coma ECG: Long QTc interval, widened QRS, tachycardia – broad complex tachyarrhythmia with long qt. Management IV Sodium Bicarbonate is the mainstay of management – indications include widened QRS > 100 or ventricular arrhythmia
58
Benzodiazepines Mechanism of action Increase frequency of chloride channel transmission – increase effects of GABA Discontinuation Withdraw benzodiazepines in steps of 1/8th at a time, every few weeks
Clinical Features of BZD withdrawal Anxiety, tremor, irritability, tinnitus, sweating and seizures – last up to 3 weeks after last dose.
59
Lithium Lithium is a mood stabiliser, commonly used in the management of bipolar affective disorder (BAD) Side effects/complications Nausea and vomiting Fine tremor (a coarse tremor suggests toxicity) Nephrogenic diabetes insipidus Hypothyroidism Weight gain IIH Hyperparathyroidism and hypercalcaemia
Monitoring Lithium levels - measure one week after starting treatment and one week after making any adjustments to dose. Once stable, check 3 monthly. 6 monthly - BMI, UE, Calcium, TFTs If urea/cr increases or eGFR decreases, measure lithium levels more frequently than 3 monthly as higher risk of toxicity.
60
Obsessive Compulsive Disorder Obsessive-compulsive disorder (OCD) is a mental health disorder which is characterised by obsessions, compulsions, or both. Obsessions are stressful thoughts which recur despite attempts to ignore them. Compulsions are rituals performed by the patient, and are often repetitive behaviours. Often patients perform compulsions to seek relief from their obsessions.
Diagnosis of OCD The ICD-10 criteria for OCD for a diagnosis of OCD are the presence of recurrent, obsessional thoughts or compulsive acts: Obsessional thoughts: Ideas, images, impulses which enter someone's mind and are invariably distressing. Compulsive acts or rituals: Repeated, non-useful & stereotyped behaviours, often performed to prevent an unlikely but negative or harmful event. For example, hand-washing, counting, checking things repeatedly.
61
Management of obsessive-compulsive disorder
Management should be based upon the degree of functional impairment the OCD is causing the patient. Mild functional impairment 1st Line: Low intensity CBT including ERP (exposure and response prevention) 2nd line: treat as per moderate impairment Moderate functional impairment 1st Line: intensive CBT (including ERP) or SSRI (or clomipramine (TCA) as an alternative) Severe functional impairment 1st Line: SSRI AND intensive CBT
62
Management of Personality Disorders
The mainstay of management for PD is talking therapies / psychotherapies - dialectical/talking behaviour therapy.
63
Schizotypal PD
Poor social skills and avoidance of social situations due anxiety Delusions or unusual beliefs - e.g. that they can communicate with animals, or that they are able to telecommunicate They may describe a history of unusual perceptual disturbances / experiences
64
Schizoid PD
Patients with schizoid PD may show indifference and a lack of interest to many things, anhedonic. They often have limited relationships, prefer solidarity Emotionally cold, detached or blunt.
65
Paranoid PD
Highly distrusting, even of friends and colleagues Overly sensitive, and may be unforgiving to people by whom they feel insulted. They might be paranoid and preoccupied by perceived attacks on their personality/ character Worried that their partner is unfaithful or people are acting against them
66
Obsessive compulsive PD
Classically obsessed with minute details, organisation and may be 'perfectionists' in nature. They are meticulous and also might have inflexible moral or ethical views.
67
Narcissistic PD
Patients with Narcissistic PD may be self-centred / self important & see themselves as better than, or superior to other people Preoccupied with power, success and hierarchy They may take advantage of others to achieve success, and may have a lack of empathy. May come across as arrogant and exaggerate their abilities and achievements Feelings may be interspersed with fearing that they are worthless
68
Histrionic PD
Excessively outwardly emotional which can appear insincere May behave inappropriately, with flirtation, seduction, attention-seeking Inappropriate sexual behaviour Swinging moods
69
Dependent PD
DEPEND on excessive reassurance in order to make decisions. They prioritise making relationships with others, so that they might be able to seek help/reassurance & care from these relationships. Need others to take responsibility for their decisions and choices Moving quickly into a new relationship if the last one ends.
70
Borderline PD (Emotionally unstable)
Patients with borderline PD often have fears of abandonment Feelings of emptiness They may have a history of unstable & chaotic relationships with friends/family/partners. Fears of abandonment Emotionally unstable Impulsive behaviour, with a history of self harm, often as a coping mechanism "Ups and downs" There is usually a history of previous trauma
71
Avoidant PD
Patients are preoccupied with feelings that they are being judged, criticised or rejected, particularly in social situations. They may have a fear of being embarrassed and belittled. May appear very shy and reluctant to engage socially due to feelings of inadequacy As a result, they AVOID social interactions and limit working/interacting with others
72
Antisocial PD
Failure to conform to social norms - patients will often have a history of antisocial behaviour, lying, aggression and fighting, law-breaking. They may demonstrate a lack of remorse for these behaviours, and for causing harm, stealing etc. Difficulty in maintaining meaningful relationships
73
74
75
76
78
79
80
81
Postpartum Mental Health Postpartum Depression (PND)
Common, affecting 1 in 10 women postpartum Symptoms occur 1-3 months postpartum (useful differentiating factor from baby blues) Clinical features are in keeping with classical depression – anhedonia, low mood, fatigue, altered sleep/wake cycle, altered appetite Assessment: PHQ-9 OR the Edinburgh Postpartum Depression Scale Scored out of 30 – a score of > 13 suggests a depressive state Management If persistent less severe depression - refer for facilitated self help New depression: If moderate or severe PND Refer for high-intensity therapy - CBT Pharmacological Tx: SSRI / SNRI / TCA (if psychological interventions declined/not effective, or she expresses a preference for medication). If breastfeeding, paroxetine and sertraline are the SSRIs of choice – lowest milk ratio
82
Baby Blues Baby blues is very common – it can affects up to 70% of women postpartum
Clinical Features Symptoms occur shortly after birth – 3-7 days postpartum Anxiety, irritability, tearfulness, fatigue. Management: Reassurance, health visitor support
83
Postpartum Psychosis A rare, psychiatric/obstetric emergency (2/1000 women) Clinical Features: Sudden onset of severe mood swings with psychotic features (delusion and hallucinations) - typically 2-3 weeks post-partum
Management: Admit Risk in subsequent pregnancies = up to 50% risk of recurrence
84
PTSD Clinical features Reliving the traumatic event with nightmares of flashbacks Physical manifestations such as sweating, shaking, nausea/vomiting, pain. Negative self-perception Emotional numbness Hyperarousal - hypervigilance, aggression and irritability
Management Event debriefing and single session interventions following a traumatic event are not recommended. Mild symptoms (for < 4 weeks) - watchful waiting Clinically important PTSD (mod-severe symptoms with functional impairment) 1st line: Psychological therapy - trauma focussed CBT or EMDR (eye movement desensitisation and reprocessing) Drug treatment - if coexisting depression, declines or limited benefit from therapy - SSRI (sertraline) or venlafaxine. Risperidone can also be used in severe cases
85
Acute Stress Disorder Clinical Features Symptoms similar to PTSD – but occurring within the first 4 weeks following trauma
Management 1st Line: Trauma based CBT Pharmacological management: Benzodiazepines may be of use
86
Charles-Bonnet Syndrome
A differential diagnosis for those experiening visual or auditory hallucinations. In Charles-Bonnet syndrome, hallucinations occur in clear, lucid consciousness, and patients demonstrate insight. They are aware that the perceptions are hallucinatory. Causes: CBS occurs in the context of visual impairment – the most common predisposing conditions include ARMD, glaucoma, cataracts
87
Fregoli syndrome
The delusion that multiple people are in fact the same person, who is in disguise or has the ability to change appearance at will.
88
Capgras delusion
The delusion that a friend or family member has been replaced by an identical impostor
89
Folie a deux
Two individuals share the same psychiatric symptom
90
Othello Syndrome
Describes pathological jealousy – the patient is convinced beyond all reason that their partner is having any affair, without any evidence.
91
Delusional Parasitosis
The patient has a fixed, false belief that they are infested by bugs or parasites
92
De Clerambault Syndrome (ertomania)
The patient has a delusion that a celebrity or idol is in love with them
93
Specific delusional beliefs Cotard Syndrome
The patient believes that they are/or part of their body is dead Typically occurs in severe depression or psychosis
94
Management of schizophrenia 1st Line: Oral 1st or 2nd generation antipsychotics in conjunction with any of the following: Family intervention Individual CBT Art therapy
Atypical (second generation) antipsychotics are usually first line in schizophrenia due to their lower risk of EPSEs. They include: Olanzapine Risperidone Aripiprazole Quetiapine Clozapine Amisulpride Clozapine is typically reserved until the failure to control symptoms adequately despite the use of 2 or more antipsychotics for 6-8 weeks due to its risk of adverse effects (e.g. agranulocytosis).
95
Clinical Features & Schneider’s first rank symptoms Schizophrenia
Schneider’s first rank symptoms are highly suggestive of schizophrenia and include: Auditory hallucinations 2 or more voices, commonly 3rd person May be thought ‘echo’ or commentary Disorders of thought Thought insertion – the belief that one’s thoughts have been planted by another Thought withdrawal – the belief that one’s thoughts are being ‘stolen’ Thought broadcast – the belief that one’s thoughts are being broadcast to others Passivity phenomena The feeling that certain actions or feelings are being imposed on the patient, or that bodily sensations are being controlled externally Delusional perceptions Describes the process where a normal perception is interpreted to have certain delusional meanings. E.g. It is windy today, therefore I will score 100% in the MSRA Other symptoms of schizophrenia include Social withdrawal and isolation Apathy and loss of emotional response Catatonic behaviour
96
Schizophrenia Schizophrenia is a mental health disorder characterised by psychosis. Psychosis may be relapsing, or continuous, and includes symptoms of hallucinations, disorders of thought and delusions
Risk factors for schizophrenia Schizophrenia is thought to result from a combination of genetic predisposition and environmental triggers. The strongest risk factors in order of risk are: Family history – risk ratio (RR) 8 Ethnicity – Afro-Caribbean patients are highest risk – RR 5 Migration – RR 3 Cannabis use – RR 1.5
97
Section 136: Police Power to Remove to a Place of Safety
Purpose: Allows the police to remove a person from a public place to a place of safety for assessment. Criteria: The person appears to be suffering from a mental disorder and is in immediate need of care or control. Application: The police can exercise this power directly without a warrant.
98
Section 135: Warrant to Search and Remove
Purpose: Allows for the police to enter a property to remove a person to a place of safety for assessment. Criteria: There is reasonable cause to suspect that a person is suffering from a mental disorder and is being ill-treated or neglected, or is unable to care for themselves. Application: A warrant is issued by a magistrate, based on an application by an AMHP.
99
Section 5(4): Nurse’s Holding Power
Purpose: Allows a registered mental health nurse to detain an inpatient for up to 6 hours. Criteria: The person is suffering from a mental disorder. It is necessary for the health or safety of the person or for the protection of others. The doctor or approved clinician in charge of the patient’s care is not immediately available to exercise their holding power under section 5(2). Application: Initiated by a registered mental health nurse.
100
Section 5(2): Doctor’s Holding Power
Purpose: Allows an inpatient who is already voluntarily receiving treatment in a hospital to be detained for up to 72 hours, enabling an assessment for possible longer-term detention. Criteria: The person is suffering from a mental disorder. It is necessary for the health or safety of the person or for the protection of others. Application: Initiated by a doctor or approved clinician in charge of the patient’s care.
101
Section 4: Emergency Admission for Assessment
Purpose: Allows for the emergency detention of a person for up to 72 hours to enable a Mental Health Act (e.g. section 2) assessment to take place. Criteria: The person is suffering from a mental disorder. It is of urgent necessity for the person to be admitted and detained under section 2. Obtaining a second medical recommendation would involve an undesirable delay. Application: Made by an AMHP or the nearest relative, supported by one medical recommendation.
102
Section 3: Admission for Treatment
Purpose: Allows for the detention of a person for treatment for up to six months, which can be renewed. Criteria: The person is suffering from a mental disorder of a nature or degree which makes it appropriate for them to receive medical treatment in a hospital. It is necessary for the health or safety of the person or for the protection of others. Appropriate medical treatment is available. Application: Made by an AMHP or the nearest relative, supported by two medical recommendations as above.
103
Key Sections of the Mental Health Act: Section 2: Admission for Assessment
Purpose: Allows for the detention of a person for assessment (or assessment followed by treatment) for up to 28 days. Criteria: The person is suffering from a mental disorder. Detention is necessary for the person's health or safety, or for the protection of others. Application: Made by an Approved Mental Health Professional (AMHP) or the nearest relative, supported by two medical recommendations (one must be a psychiatrist, the other another doctor (GP/another psychiatrist).
104
The Mental Health Act 1983
The Mental Health Act 1983 (amended in 2007) is the key legislation in the UK that governs the assessment, treatment, and rights of individuals with mental health disorders . It provides the legal framework for detaining and treating people who pose a risk to themselves or others due to mental health issues. The Act aims to balance the need for care and control with respect for patients' rights and liberties.
105
Sections of the Mental Health Act 1983
Key Learning: The Mental Health Act 1983 governs the assessment, treatment, and rights of individuals with mental disorders. People may be detained according to the following sections. Section 2: Admission for assessment up to 28 days. Section 3: Detention for treatment up to 6 months. Section 4: Emergency assessment up to 72 hours. Section 5(2): Doctor's holding power - Detention of an inpatient for assessment up to 72 hours. Section 5(4): Nurse's holding power - Detention of an inpatient for up to 6 hours. Section 135: Police search and remove from a property to place of safety for assessment. Section 136: Police power to remove from a public place to place of safety for assessment.
106
The Mental Health Act 1983
The Mental Health Act 1983 (amended in 2007) is the key legislation in the UK that governs the assessment, treatment, and rights of individuals with mental health disorders. It provides the legal framework for detaining and treating people who pose a risk to themselves or others due to mental health issues. The Act aims to balance the need for care and control with respect for patients' rights and liberties.
107
Unexplained Symptoms Somatisation Disorder
Patient complains of multiple physical symptoms and refuses to accept negative test results Tip: Somatisation = Symptoms
108
HypoChondriasis
Also known as illness anxiety disorder, hypochondriasis describes an irrational belief that oneself has an underlying serious condition (such as cancer) to such an extent that they will even refute the validity of negative test results Tip: HypoChondriasis = Condition/Cancer
109
Conversion Disorder
Conversion disorder presents with a loss of motor or sensory function (which is not consciously feigned by the patient). May be associated with la belle indifference (a paradoxical lack of concern regarding a seemingly serious issue) - the patient might not seem to care
110
Dissociative Disorders
A range of psychiatric disorders, usually as a result of trauma/stress (e.g. childhood trauma) with features including A feeling of disconnect from the world Amnesia - forgetting important personal information/ memories Identity problems - feeling uncertain about who one is, multiple personality disorder Patients can have episodes of dissociation (with above symptoms) for hours to months. The 3 main dissociative disorders include: Depersonalisation-derealisation DID (dissociative identity disorder) Dissociative amnesia
111
Factitious Disorder (Munchausen's)
FD is the intentional feigning of symptoms without a clear motivation
112
Malingering
Feigning of symptoms for personal gain (e.g. financial compensation, time off of work) etc.
113
114